Metraipolis › archive › dc_f124547beabb
Nanozymes in the Treatment of Pediatric Inflammatory Diseases: Opportunities and Challenges — Europe PMC PMID:42515742
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42515742
- DOI
- 10.3390/ph19071061
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T09:30:20.000Z
- SHA-256 of the archived text
f5efa05b22b93317f1ffbe0ee6dafd0a577bee4ed77f54327a42afbc75bf30b4- Stable URL of this page
https://metraipolis.com/documento/dc_f124547beabb
How to cite
Nanozymes in the Treatment of Pediatric Inflammatory Diseases: Opportunities and Challenges — Europe PMC PMID:42515742 — Europe PMC (en), https://europepmc.org/article/MED/42515742 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f124547beabb (Metraipolis archive dc_f124547beabb, sha256 f5efa05b22b93317f1ffbe0ee6dafd0a577bee4ed77f54327a42afbc75bf30b4)
BibTeX
@misc{dcf124547beabb,
title = {Nanozymes in the Treatment of Pediatric Inflammatory Diseases: Opportunities and Challenges — Europe PMC PMID:42515742},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42515742},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f124547beabb; sha256 f5efa05b22b93317f1ffbe0ee6dafd0a577bee4ed77f54327a42afbc75bf30b4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42515742. Agents can read the archived copy with the MCP tool read_document.